Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 126-150 of 509 matching filings.

Per page
25
Current page
6
10-K File 001-40023

10-K filing

Filing date
30 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
SC 13G File 005-32837

SC 13G filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-267870

424B5 filing

Filing date
04 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40023

10-Q filing

Filing date
31 Oct 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
EFFECT File 333-267870

EFFECT filing

Filing date
20 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-267870

S-3 filing

Filing date
13 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40023

DEFA14A filing

Filing date
04 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40023

8-K/A filing

Filing date
17 Aug 2022
Reporting date
08 Jun 2022
Next action
Verify source filing
DEF 14A File 001-40023

DEF 14A filing

Filing date
17 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40023

10-Q filing

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
S-8 File 333-266316

S-8 filing

Filing date
25 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jul 2022
Reporting date
15 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .